ArticlePakistan journal of medical sciences2026
Predictive value and application of thrombelastography combined with coagulation parameters for adverse pregnancy outcomes.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the predictive value and clinical utility of thrombelastography (TEG) combined with coagulation parameters for adverse pregnancy outcomes(APOs). Methodology: A retrospective analysis was conducted on the clinical data of 186 pregnant women admitted to the Department of Obstetrics in Affiliated Hospital of Chengde Medical College between January 2022 and June 2025. Based on pregnancy outcomes, patients were classified into the APO group and the normal pregnancy outcome group. Baseline characteristics, TEG parameters, and coagulation parameters were compared between groups. Pearson correlation analysis was performed to assess associations between TEG and coagulation parameters in the APO group. Results: No significant differences were observed between the two groups in baseline characteristics such as age, gravidity, parity, and gestational weight gain (all P > 0.05), indicating comparability. Regarding TEG parameters, the APO group showed lower R values and higher maximum amplitude (MA) and coagulation index (CI) values compared with the normal outcome group (P < 0.05, respectively). For coagulation parameters, fibrinogen (FIB) and D-dimer (D-D) levels were significantly elevated, while antithrombin III (AT-III) levels were decreased in the APO group (P < 0.05, respectively). Conclusion: The combination of TEG and coagulation parameters demonstrates higher predictive efficiency for APOs than either method alone, providing a reliable basis for the early identification of high-risk populations and guiding clinical intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.